Tomer Yaron-Barir, MD, PhD

Physician at Boston Children’s | Scientist at Dana-Farber – Harvard | Co-Founder & CSO fighting cancer resistance | STAT Wunderkind | Forbes 30 Under 30 Science

United States

About

Experience

  • Co-Founder & CSO at Marendis Therapeutics
    Jul 2025 - Present · 1 yr 1 mo

  • Resident Physician at Boston Children's Hospital
    Jun 2025 - Present · 1 yr 2 mos

  • Dana-Farber Cancer Institute (4 yrs)
    • Researcher
      Apr 2025 - Present · 1 yr 4 mos

      Continuing development of the Kinase Library and applying it to dissect phosphorylation signaling in cancer and other diseases. Focused on integrating AI-driven analysis with mass-spec phosphoproteomics to identify therapeutic targets and disease mechanisms.

    • Research Affiliate
      Aug 2022 - Mar 2025 · 2 yrs 8 mos

      Developed and expanded the Kinase Library, applying computational methods to investigate phosphorylation-driven mechanisms across cancer, lupus, endometriosis, Alzheimer’s disease, and other signaling-related conditions. Collaborated closely with the Cantley Lab on high-impact, multi-omics studies.

  • Co-Founder at Destroke
    Feb 2019 - Present · 7 yrs 6 mos

  • Medical Candidate at Columbia University Vagelos College of Physicians and Surgeons
    Aug 2022 - May 2025 · 2 yrs 10 mos

    3-year PhD-to-MD program Dean's Scholar Emmett Holt Fellowship